Key facts
- This page summarizes Vance R. Brown's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 17 Feb 2026, 19:05.
Vance R. Brown - 12 Feb 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)
- Reporting relationship
- EVP, GC and Corp. Secretary
- Issuer ticker
- BSX
- Reported as of
- 12 Feb 2026
- Net transaction value
- -$36,171
- SEC form
- 4
- Accepted by SEC
- 17 Feb 2026, 19:05:48 UTC
- Prior SEC filing
- 02 Jul 2025
- Next SEC filing
- 18 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Susan Thompson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Vance R. Brown filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 17 Feb 2026.
Change
- Previous filing in this sequence was filed on 02 Jul 2025.
- Current net transaction value: -$36,171.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001868243
Primary reporting owner
Brown Vance R
- Relationship
- EVP, GC and Corp. Secretary
- Address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH
- Signature
- /s/ Susan Thompson, Attorney-in-Fact
- Signature date
- 17 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,442
- Change %
- +4.3%
- Price
- $0.000000
- Shares after
- 34,893
- Date
- 12 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
BSX
transaction
Common Stock
Tax liability
- Transaction value
- $36,171
- Shares
- -488
- Change %
- -1.4%
- Price
- $74.12
- Shares after
- 34,405
- Date
- 12 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BSX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,442
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 2,886
- Date
- 12 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,442
- Exercise price
- Footnotes
- F1, F2
BSX
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +7,420
- Change %
- Price
- $0.000000
- Shares after
- 7,420
- Date
- 12 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,420
- Exercise price
- Footnotes
- F1, F3
BSX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +17,510
- Change %
- Price
- $0.000000
- Shares after
- 17,510
- Date
- 12 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,510
- Exercise price
- $74.12
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Footnote F2
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
Footnote F3
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.
Footnote F4
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.